Bushra Khan, et al. “RISK OF ENDOMETRIAL HYPERPLASIA AND MALIGNANCY AMONG WOMEN USING TAMOXIFEN: A COMPARATIVE CLINICAL STUDY”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 11, Nov. 2024, pp. 2724-30, https://doi.org/10.53555/2hv25555.